Praxis Precision Medicines, Inc. (PRAX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 149 transactions totaling $62.3M, demonstrating a bearish sentiment with -$51.6M in net insider flow. The most recent transaction on Jan 12, 2026 involved a transaction of 943 shares valued at $260.0K.
No significant insider buying has been recorded for PRAX in the recent period.
No significant insider selling has been recorded for PRAX in the recent period.
Based on recent SEC filings, insider sentiment for PRAX is bearish with an Insider Alignment Score of 9/100 and a net flow of -$51.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Praxis Precision Medicines, Inc. (PRAX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading PRAX stock, having executed 149 transactions in the past 90 days. The most active insider is Phillip Gross (Executive), who has made 10 transactions totaling $33.2M.
Get notified when executives and directors at PRAX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Edwin Kelly Timothy | Chief Financial Officer | Payment | 943 | $275.74 | $260.0K | C-Suite |
| Jan 12, 2026 | Nemiroff Alex | General Counsel and Secretary | Payment | 768 | $275.74 | $211.8K | |
| Jan 12, 2026 | Sniecinski Megan | Chief Operating Officer | Payment | 885 | $275.74 | $244.0K | C-Suite |
| Jan 12, 2026 | Mastrocola Lauren | Principal Accounting Officer | Payment | 344 | $275.74 | $94.9K | |
| Jan 10, 2026 | Sniecinski Megan | Chief Operating Officer | Payment | 1,087 | $288.45 | $313.5K | C-Suite |
| Jan 10, 2026 | Mastrocola Lauren | Principal Accounting Officer | Payment | 367 | $288.45 | $105.9K | |
| Jan 10, 2026 | Souza Marcio | Executive | Payment | 4,252 | $288.45 | $1.2M | Large |
| Jan 10, 2026 | Edwin Kelly Timothy | Chief Financial Officer | Payment | 1,335 | $288.45 | $385.1K | C-Suite |
| Jan 10, 2026 | Nemiroff Alex | General Counsel and Secretary | Payment | 917 | $288.45 | $264.5K | |
| Jan 8, 2026 | Sniecinski Megan | Chief Operating Officer | Award | 7,700 | $N/A | $0 | C-Suite |
| Jan 8, 2026 | Sniecinski Megan | Chief Operating Officer | Award | 9,625 | $N/A | $0 | C-Suite |
| Jan 8, 2026 | Mastrocola Lauren | Principal Accounting Officer | Award | 7,500 | $N/A | $0 | |
| Jan 8, 2026 | Mastrocola Lauren | Principal Accounting Officer | Award | 3,750 | $N/A | $0 | |
| Jan 8, 2026 | Souza Marcio | Executive | Award | 22,110 | $N/A | $0 | |
| Jan 8, 2026 | Souza Marcio | Executive | Award | 27,640 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 27 | $56.9M | 82.2% |
Purchase(P) | 16 | $5.4M | 7.7% |
Payment(F) | 31 | $3.4M | 5.0% |
Exercise(M) | 17 | $3.3M | 4.8% |
Award(A) | 38 | $176.5K | 0.3% |
Gift(G) | 1 | $0 | 0.0% |
Other(J) | 3 | $0 | 0.0% |
Conversion(C) | 16 | $0 | 0.0% |
Insider selling pressure at Praxis Precision Medicines, Inc. has increased, with 22 insiders executing 149 transactions across all time. Total sales of $56.9M significantly outpace purchases of $5.4M, resulting in a net outflow of $51.6M. This selling activity appears largely discretionary, which may warrant closer attention from investors.